Cite

HARVARD Citation

    Randon, G. et al. (2022). Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer. European journal of cancer. pp. 90-98. [Online]. 
  
Back to record